Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adolescent Males
100%
Pemphigus Vulgaris
100%
Rituximab
100%
Autoimmune Disease
28%
Adverse Effects
14%
Mechanism of Action
14%
CD4+ T Cells
14%
Plasma Cells
14%
Malignancy
14%
Autoantibodies
14%
Autoimmune
14%
B Cells
14%
Antigen Presentation
14%
Medication Use
14%
Remission
14%
Therapeutic Benefits
14%
Weekly Dosing
14%
Potential Side Effects
14%
Successful Treatment
14%
Dermatological Diseases
14%
Dosing Regimen
14%
Pemphigus
14%
Dosing Strategy
14%
Autoreactive
14%
Chimeric Monoclonal Antibody
14%
CD20
14%
Rheumatologic Diseases
14%
B-cell Malignancies
14%
B-cell Depletion
14%
Recent Update
14%
Autoreactive B Cells
14%
Medicine and Dentistry
Dermatological Agent
100%
Pemphigus vulgaris
100%
Rituximab
100%
B Cell
57%
Diseases
42%
Cancer
28%
Infusion
28%
Autoimmune Disease
28%
Monoclonal Antibody
14%
T-Helper Cell
14%
Dermatology
14%
Antigen Presentation
14%
Autoimmunity
14%
Autoantibodies
14%
CD20
14%
Pemphigus
14%
Immunoglobulin Producing Cell
14%
Adverse Effect
14%
Side Effect
14%
Pharmacology, Toxicology and Pharmaceutical Science
Dermatological Agent
100%
Rituximab
100%
Pemphigus vulgaris
100%
Diseases
42%
Autoimmune Disease
28%
Monoclonal Antibody
14%
Autoantibodies
14%
Remission
14%
Pemphigus
14%
Side Effect
14%